← Evidence map

TrialDiabetologia1996

Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group.

S Kumar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

31 papers cite it

2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
1996
this paperpooled ittrialcites it

2 trials

NCT0019489664 enrolled2000NCT00458133262 enrolled2007
Full record →Abstract, authors, funding and every citing paper · PMID 8781766